Hepatitis B virus surface protein mutations clustered mainly in CTL immune epitopes in chronic carriers: Results of an Iranian nationwide study

Journal of Viral Hepatitis

Volumn 20, Issue 7, 2013, Pages 494-501

  Khedive, A ^a   Norouzi, M ^a   Ramezani, F ^a   Karimzadeh, H ^a   Alavian, S M ^b   Malekzadeh, R ^c   Montazeri, G ^c   Nejatizadeh, A ^d   Ziaee, M ^e   Abedi, F ^f   Ataei, B ^g   Yaran, M ^g   Sayad, B ^h   Somi, M H ⁱ   Sarizadeh, G ^j   Sanei Moghaddam, I ^k   Mansour Ghanaei, F ^l   Rafatpanah, H ^m   Pourhosseingholi, M A ⁿ   Keyvani, H ^o   Kalantari, E ^p   Saberifiroozi, M ^q   Judaki, M A ^a   Ghamari, S ^a   Daram, M ^a   Mahabadi, M ^a   Fazeli, Z ^a   Goodarzi, Z ^a   Poortahmasebi, V ^a   Jazayeri, S M ^a   more..

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Middle East Liver Diseases Center (MELD Centers)   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d HORMOZGAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e BIRJAND UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^h Kermanshah Liver Diseases and Hepatitis Research Center   (Iran)

ⁱ TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^j Educational Region of Khozestan Blood Transfusion Organization   (Iran)

^k ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^l GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^m MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

ⁿ SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^o TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^p Gholhack Medical Laboratory   (Iran)

^q SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

more..

Author keywords

Chronic HBV carriers; HBV escape mutations; HBV immune epitopes; HBV T cell

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINO ACID SUBSTITUTION; ARTICLE; B LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HELPER CELL; HEPATITIS B VIRUS; HUMAN; IMMUNOSURVEILLANCE; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; STOP CODON; VIRUS LOAD;

ADULT; AMINO ACID SUBSTITUTION; CARRIER STATE; CROSS-SECTIONAL STUDIES; DNA, VIRAL; EPITOPES, T-LYMPHOCYTE; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNE EVASION; IRAN; MALE; MIDDLE AGED; MUTATION, MISSENSE; SEQUENCE ANALYSIS, DNA; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84878562416     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12045     Document Type: Article

References (48)

1. World Hepatitis Alliance. Viral Hepatitis: Global Policy. Washington, DC: Regional Office for the Americas of the World Health Organization, 2010.
2. Rizzetto M,. Treatment of hepatitis B virus cirrhosis. Hepat Mon 2012; 12 (5): 309-311.
3. Hollinger F, Liang TJ,. Hepatitis B Virus. In:, Knipe D, Howley P, eds. Fields Virology. 4 edn. Philadelphia: Lippincott Williams&Willkins; 2001. 2923-2969.
4. Taheri H, Hasanjani Roushan MR, Soleimani Amiri MJ, Pouralijan M, Bijani A,. Efficacy of Hepatitis B vaccine in those who lost Hepatitis B surface antigen during follow-up: efficacy of HBV vaccine in those who lost HBsAg. Hepat Mon 2011; 11 (2): 119-122.
5. Rehermann B, Fowler P, Sidney J, et al,. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med 1995; 181 (3): 1047-1058.
6. Chisari FV,. Rous-Whipple award lecture. Viruses, immunity, and cancer: lessons from hepatitis B. Am J Pathol 2000; 156 (4): 1117-1132.
7. Milich DR, Leroux-Roels GG,. Immunogenetics of the response to HBsAg vaccination. Autoimmun Rev 2003; 2 (5): 248-257.
8. Sobao Y, Sugi K, Tomiyama H, et al,. Identification of hepatitis B virus-specific CTL epitopes presented by HLA-A*2402, the most common HLA class I allele in East Asia. J Hepatol 2001; 34 (6): 922-929.
9. Chisari FV, Ferrari C,. Hepatitis B virus immunopathology. Springer Semin Immunopathol 1995; 3: 261-281.
10. Reignat S, Webster GJ, Brown D, et al,. Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J Exp Med 2002; 195 (9): 1089-1101.
11. Hyodo N, Tajimi M, Ugajin T, Nakamura I, Imawari M,. Frequencies of interferon-gamma and interleukin-10 secreting cells in peripheral blood mononuclear cells and liver infiltrating lymphocytes in chronic hepatitis B virus infection. Hepatol Res 2003; 27 (2): 109-116.
12. Milich DR,. Influence of T-helper cell subsets and crossregulation in hepatitis B virus infection. J Viral Hepat 1997; 4 (Suppl 2): 48-59.
13. Barnaba V, Franco A, Paroli M, et al,. Selective expansion of cytotoxic T lymphocytes with a CD4 + CD56 + surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with Hepatitis B virus. J Immunol 1994; 152 (6): 3074-3087.
14. Ducos J, Bianchi-Mondain AM, Pageaux G, et al,. Hepatitis B virus (HBV)-specific in vitro antibody production by peripheral blood mononuclear cells (PBMC) after vaccination by recombinant hepatitis B surface antigen (rHBsAg). Clin Exp Immunol 1996; 103 (1): 15-18.
15. Mancini-Bourgine M, Fontaine H, Brechot C, Pol S, Michel ML,. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers. Vaccine 2006; 24 (21): 4482-4489.
16. Tai PC, Banik D, Lin GI, et al,. Novel and frequent mutations of hepatitis B virus coincide with a major histocompatibility complex class I-restricted T-cell epitope of the surface antigen. J Virol 1997; 71 (6): 4852-4856.
17. Honorati MC, Dolzani P, Mariani E, et al,. Epitope specificity of Th0/Th2 CD4 + T-lymphocyte clones induced by vaccination with rHBsAg vaccine. Gastroenterology 1997; 112 (6): 2017-2027.
18. Carman WF, Korula J, Wallace L, MacPhee R, Mimms L, Decker R,. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet 1995; 345 (8962): 1406-1407.
19. Ijaz S, Ferns RB, Tedder RS,. A 'first loop' linear epitope accessible on native hepatitis B surface antigen that persists in the face of 'second loop' immune escape. J Gen Virol 2003; 2: 269-275.
20. Yamamoto K, Horikita M, Tsuda F, et al,. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol 1994; 68 (4): 2671-2676.
21. Carman WF,. The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat 1997; 4 (Suppl 1): 11-20.
22. Carman WF, Zanetti AR, Karayiannis P, et al,. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990; 336 (8711): 325-329.
23. Ghany MG, Ayola B, Villamil FG, et al,. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 1998; 27 (1): 213-222.
24. Okamoto H, Yano K, Nozaki Y, et al,. Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine. Pediatr Res 1992; 32 (3): 264-268.
25. Protzer-Knolle U, Naumann U, Bartenschlager R, et al,. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology 1998; 27 (1): 254-263.
26. Ireland JH, O'Donnell B, Basuni AA, et al,. Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays. Hepatology 2000; 31 (5): 1176-1182.
27. Weber B,. Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene. J Med Virol 2006; 78 (Suppl 1): S59-S65.
28. Hollinger FB,. Hepatitis B virus genetic diversity and its impact on diagnostic assays. J Viral Hepat 2007; 14 (Suppl 1): 11-15.
29. Weber B,. Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. J Clin Virol 2005; 32 (2): 102-112.
30. Dindoost P, Jazayeri S, Karimzadeh H, Saberfar E, Miri S, Alavian SM,. HBsAg variants: common escape issues. Jundishapur J Microbiol 2012; 5 (4): 521-527.
31. Jazayeri M, Basuni AA, Sran N, et al,. HBV core sequence: definition of genotype-specific variability and correlation with geographical origin. J Viral Hepat 2004; 11 (6): 488-501.
32. Guptan RC, Thakur V, Sarin SK, Banerjee K, Khandekar P,. Frequency and clinical profile of precore and surface hepatitis B mutants in Asian-Indian patients with chronic liver disease. Am J Gastroenterol 1996; 91 (7): 1312-1317.
33. Norouzi M, Ataei B, Yaran M, et al,. Hepatitis B virus surface antigen variants clustered within immune epitopes in chronic Hepatitis B carriers from Hormozgan province, South of Iran. Iran J Basic Med Sci 2010; 13 (4): 11.
34. Sayad B, Anvari FA, Alavian SM, et al,. Correlation of Hepatitis B surface antigen mutations with clinical status of the chronically infected patients from Kermanshah, West of Iran. Minerva Gastroenterol Dietol 2012; 58 (1): 9-18.
35. Bauer T, Weinberger K, Jilg W,. Variants of two major T cell epitopes within the hepatitis B surface antigen are not recognized by specific T helper cells of vaccinated individuals. Hepatology 2002; 35 (2): 455-465.
36. Kfoury Baz EM, Zheng J, Mazuruk K, Van Le A, Peterson DL,. Characterization of a novel hepatitis B virus mutant: demonstration of mutation-induced hepatitis B virus surface antigen group specific 'a' determinant conformation change and its application in diagnostic assays. Transfus Med 2001; 11 (5): 355-362.
37. Chen WN, Oon CJ,. Hepatitis B virus surface antigen (HBsAg) mutants in Singapore adults and vaccinated children with high anti-hepatitis B virus antibody levels but negative for HBsAg. J Clin Microbiol 2000; 38 (7): 2793-2794.
38. Coleman PF, Chen YC, Mushahwar IK,. Immunoassay detection of hepatitis B surface antigen mutants. J Med Virol 1999; 59 (1): 19-24.
39. Mu SC, Lin YM, Jow GM, Chen BF,. Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan. J Hepatol 2009; 50 (2): 264-272.
40. Oon CJ, Chen WN,. Current aspects of hepatitis B surface antigen mutants in Singapore. J Viral Hepat 1998; 5 (Suppl 2): 17-23.
41. Oon CJ NC, Shiuan K, Keow LG,. Identification of hepatitis B surface antigen variants with alterations outside the 'a' determinant in immunized Singapore infants. J Infect Dis 1999; 179: 5.
42. Zheng X, Weinberger KM, Gehrke R, et al,. Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity. Virology 2004; 329 (2): 454-464.
43. Jazayeri S, Carman W,. Virus escape, CTL or B cell Epitopes? Hepat Mon 2005; 5 (4): 4.
44. Hultgren C, Milich DR, Weiland O, Sallberg M,. The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses. J Gen Virol 1998; 10: 2381-2391.
45. Ijaz S, Torre F, Tedder RS, Williams R, Naoumov NV,. Novel immunoassay for the detection of hepatitis B surface 'escape' mutants and its application in liver transplant recipients. J Med Virol 2001; 63 (3): 210-216.
46. Ferrari C, Penna A, Bertoletti A, et al,. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol 1990; 145 (10): 3442-3449.
47. Peng G, Luo B, Li J, et al,. Hepatitis B e-antigen Persistency is Associated with the Properties of HBV-Specific CD8 T Cells in CHB Patients. J Clin Immunol 2009; 28 (1): 114-119.
48. Wieland A, Riedl P, Reimann J, Schirmbeck R,. Silencing an immunodominant epitope of hepatitis B surface antigen reveals an alternative repertoire of CD8 T cell epitopes of this viral antigen. Vaccine 2009; 28 (1): 114-119.